Efficacy of beta blocker for the patients with acute coronary syndrome undergoing primary percutaneous coronary intervention

Trial Profile

Efficacy of beta blocker for the patients with acute coronary syndrome undergoing primary percutaneous coronary intervention

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 May 2013

At a glance

  • Drugs Landiolol (Primary)
  • Indications Acute coronary syndromes; Arrhythmias; Heart failure
  • Focus Adverse reactions; Biomarker; Therapeutic Use
  • Most Recent Events

    • 16 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top